The Silent Pandemic of Antimicrobial Resistance examines one of the most dangerous and least visible global health threats of the modern era. As antibiotics lose effectiveness, infections once considered routine are becoming harder—and sometimes impossible—to treat, quietly undermining the foundations of modern medicine. Blending history, epidemiology, health systems analysis, and policy, the book traces how antimicrobial resistance (AMR) emerged through decades of overuse, underinvestment, and fragmented global governance. It places today's crisis in context by examining past pandemics, including the Black Death, the 1918 influenza pandemic, and COVID-19, showing how biological threats exploit systemic weaknesses in healthcare, economies, and public trust. Moving beyond microbiology, the book explores AMR as a systems-level risk with cascading consequences: prolonged hospitalizations, ICU saturation, workforce burnout, rising healthcare costs, weakened supply chains, and growing inequality between high- and low-income regions. It also examines why innovation in antibiotics and diagnostics has stalled, and how current economic incentives fail to reward stewardship or preparedness. Ultimately, The Silent Pandemic of Antimicrobial Resistance is both a warning and a roadmap. It argues that AMR is not a distant future problem but a present and accelerating crisis—and that coordinated action in surveillance, stewardship, innovation, and global governance can still prevent a post-antibiotic era. The book is written for healthcare leaders, policymakers, researchers, and informed readers seeking to understand how a slow-moving biological threat could become the next global catastrophe if left unaddressed.